Alzheimer, FDA approva test del sangue per diagnosi dai 40 anni in su: “Accurato come scansioni cerebrali”

FDA clears PrecivityAD2, Alzheimer's disease blood test for as early as age 40 years

The FDA has cleared PrecivityAD2, a single blood test designed to help health care professionals rule in or rule out an Alzheimer’s disease diagnosis, according to a press release from the test’s developer,…